AI Science Tracker
EN

Department of Urology

3 discoveries from 2023 to 2025

Discoveries

Integrative transcriptomic and machine learning analyses identify HDAC9 as a key regulator of mitochondrial dysfunction and senescence-associated inflammation in diabetic nephropathy.

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine learning selected five diabetic-nephropathy genes; external datasets, single-cell data and HDAC9 perturbation assays support a specific mechanistic candidate.

Technology: Integrated transcriptomics and learned feature selection are tested against external datasets and cell assays, including HDAC9 knockdown.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Integrated transcriptomics and learned feature selection are tested against external datasets and cell assays, including HDAC9 knockdown.
Test and result
Evidence supports an HDAC9-associated molecular result; no claim of patient-level causal effect or therapeutic benefit.
Limitation / still unknown
Primary Results describe the specific comparator, cohort or experimental check; limitations are stated narrowly.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1627173/full · https://europepmc.org/article/MED/40948769 · https://pubmed.ncbi.nlm.nih.gov/40948769/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Machine Learning-Based Prediction of Post-Operative Systemic Inflammatory Response Syndrome Following Pediatric Percutaneous Nephrolithotripsy.

Source check: Source checked. Not independent scientific confirmation.

Finding: Among 410 patients, postoperative SIRS incidence was 20.24%; LightGBM achieved AUC 0.8576 and F1 0.6154, outperforming two adult models in this pediatric cohort. Retrospective single-center development/validation supports prediction within this population; external validation and improved patient outcomes are not established.

Technology: Eight machine-learning algorithms were trained to predict postoperative SIRS after pediatric percutaneous nephrolithotripsy; LASSO and Boruta selected predictors, with SHAP interpretation.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Eight machine-learning algorithms were trained to predict postoperative SIRS after pediatric percutaneous nephrolithotripsy; LASSO and Boruta selected predictors, with SHAP interpretation.
Test and result
Among 410 patients, postoperative SIRS incidence was 20.24%; LightGBM achieved AUC 0.8576 and F1 0.6154, outperforming two adult models in this pediatric cohort.
Limitation / still unknown
Retrospective single-center development/validation supports prediction within this population; external validation and improved patient outcomes are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12134469/ · https://pubmed.ncbi.nlm.nih.gov/40470304/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.